• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Needle Biopsy Market

    ID: MRFR/MED/2542-HCR
    110 Pages
    Rahul Gotadki
    October 2025

    Needle Biopsy Market Size, Growth Research Report By Type (Fine Needle Aspiration Biopsy, Core Needle Biopsy, Vacuum-Assisted Biopsy), By Application (Oncology, Cardiology, Gastroenterology, Pulmonology), By Guidance Technique (Ultrasound Guided, CT Guided, Mammography Guided), By End Use (Hospitals, Diagnostic Laboratories, Research Institutions) - Competitor Industry Analysis and Trends Forecast Till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Needle Biopsy Market Infographic
    Purchase Options

    Needle Biopsy Market Summary

    As per MRFR analysis, the Needle Biopsy Market Size was estimated at 2.35 USD Billion in 2024. The Needle Biopsy industry is projected to grow from 2.465 USD Billion in 2025 to 3.982 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 4.91 during the forecast period 2025 - 2035.

    Key Market Trends & Highlights

    The Needle Biopsy Market is poised for substantial growth driven by technological advancements and increasing demand for minimally invasive procedures.

    • North America remains the largest market for needle biopsy, driven by advanced healthcare infrastructure and high diagnostic imaging utilization.
    • The Asia-Pacific region is emerging as the fastest-growing market, fueled by rising healthcare investments and increasing cancer prevalence.
    • Fine Needle Aspiration Biopsy continues to dominate the market, while Core Needle Biopsy is experiencing rapid growth due to its effectiveness in tissue sampling.
    • Key market drivers include the rising incidence of cancer and a growing preference for minimally invasive procedures, enhancing the overall market landscape.

    Market Size & Forecast

    2024 Market Size 2.35 (USD Billion)
    2035 Market Size 3.982 (USD Billion)
    CAGR (2025 - 2035) 4.91%

    Major Players

    Becton Dickinson and Company (US), Boston Scientific Corporation (US), Medtronic plc (IE), Hologic, Inc. (US), Siemens Healthineers AG (DE), Fujifilm Holdings Corporation (JP), Cook Medical Incorporated (US), Cardinal Health, Inc. (US), Terumo Corporation (JP)

    Needle Biopsy Market Trends

    The Needle Biopsy Market is currently experiencing a notable transformation, driven by advancements in technology and an increasing emphasis on minimally invasive procedures. This market appears to be expanding as healthcare providers and patients alike recognize the benefits of needle biopsies, which include reduced recovery times and lower complication rates compared to traditional surgical methods. Furthermore, the growing prevalence of cancer and other chronic diseases necessitates more efficient diagnostic tools, thereby propelling the demand for needle biopsy procedures. As a result, various stakeholders, including medical device manufacturers and healthcare institutions, are investing in innovative solutions to enhance the accuracy and safety of these procedures. In addition to technological advancements, the Needle Biopsy Market is influenced by evolving regulatory frameworks and increased awareness among healthcare professionals regarding the advantages of early diagnosis. The integration of imaging technologies, such as ultrasound and MRI, into needle biopsy procedures is likely to improve precision and patient outcomes. Moreover, the rising trend of personalized medicine may further drive the adoption of needle biopsies, as tailored treatment plans require accurate tissue sampling. Overall, the Needle Biopsy Market appears poised for growth, with ongoing developments suggesting a promising future for both practitioners and patients alike.

    Technological Advancements

    The Needle Biopsy Market is witnessing a surge in technological innovations, particularly in imaging techniques and biopsy devices. Enhanced imaging modalities, such as ultrasound and MRI, are being integrated into procedures, improving accuracy and reducing complications. These advancements facilitate real-time guidance during biopsies, which may lead to better diagnostic outcomes.

    Minimally Invasive Procedures

    There is a growing preference for minimally invasive procedures within the Needle Biopsy Market. Patients and healthcare providers are increasingly recognizing the benefits of reduced recovery times and lower risks associated with needle biopsies compared to traditional surgical methods. This trend is likely to drive further adoption of needle biopsy techniques.

    Personalized Medicine

    The rise of personalized medicine is influencing the Needle Biopsy Market significantly. As treatment plans become more tailored to individual patient needs, the demand for precise tissue sampling is increasing. Needle biopsies provide essential information for developing targeted therapies, thereby enhancing their relevance in modern healthcare.

    The increasing prevalence of chronic diseases and advancements in minimally invasive procedures are driving the demand for needle biopsy techniques, which are becoming essential in diagnostic practices.

    U.S. National Institutes of Health (NIH)

    Needle Biopsy Market Drivers

    Technological Innovations

    Technological advancements in needle biopsy techniques are transforming the Needle Biopsy Market. Innovations such as ultrasound-guided biopsies and robotic-assisted systems enhance precision and reduce complications. These technologies allow for better visualization and targeting of lesions, which is particularly beneficial in challenging anatomical locations. The integration of imaging technologies has led to a notable increase in the accuracy of needle biopsies, thereby boosting their adoption in clinical settings. Furthermore, the development of specialized needles and devices has improved the overall patient experience, making procedures quicker and less painful. As these technologies continue to evolve, the Needle Biopsy Market is expected to witness substantial growth, driven by the demand for safer and more effective diagnostic tools.

    Rising Incidence of Cancer

    The increasing prevalence of cancer worldwide is a primary driver for the Needle Biopsy Market. As cancer cases rise, the demand for accurate and early diagnosis intensifies. Needle biopsy procedures are essential for obtaining tissue samples, which are crucial for determining the presence and type of cancer. According to recent statistics, cancer is projected to affect millions annually, necessitating advanced diagnostic techniques. This trend indicates a growing reliance on needle biopsies, as they provide a less invasive option compared to traditional surgical biopsies. The Needle Biopsy Market is likely to expand significantly as healthcare providers seek efficient methods to diagnose cancer, thereby improving patient outcomes and treatment plans.

    Rising Awareness and Education

    The increasing awareness and education regarding the benefits of needle biopsies are contributing to the growth of the Needle Biopsy Market. Healthcare professionals and patients are becoming more informed about the advantages of needle biopsies, including their accuracy, safety, and minimal invasiveness. Educational initiatives and campaigns aimed at both medical practitioners and the general public are fostering a better understanding of when and why needle biopsies are necessary. This heightened awareness is likely to lead to an increase in the number of procedures performed, as more patients seek these options for diagnosis. Consequently, the Needle Biopsy Market is poised for expansion as awareness continues to grow.

    Increase in Diagnostic Imaging Utilization

    The growing utilization of diagnostic imaging techniques is significantly influencing the Needle Biopsy Market. Imaging modalities such as MRI, CT scans, and ultrasound are increasingly employed to guide needle biopsies, enhancing their accuracy and effectiveness. This trend is particularly evident in oncology, where precise localization of tumors is critical for successful diagnosis and treatment planning. The integration of imaging technologies with needle biopsy procedures has led to improved patient outcomes and reduced complications. As healthcare providers continue to adopt advanced imaging techniques, the Needle Biopsy Market is expected to experience growth, driven by the need for accurate and reliable diagnostic methods.

    Growing Preference for Minimally Invasive Procedures

    The shift towards minimally invasive procedures is a significant factor propelling the Needle Biopsy Market. Patients and healthcare providers increasingly favor techniques that minimize recovery time and reduce surgical risks. Needle biopsies, being less invasive than traditional surgical methods, align with this trend. They typically require only local anesthesia and can often be performed on an outpatient basis, which appeals to both patients and healthcare systems. This preference is reflected in the rising number of needle biopsy procedures conducted annually, as they offer a balance between diagnostic efficacy and patient comfort. Consequently, the Needle Biopsy Market is likely to expand as more healthcare facilities adopt these procedures to meet patient demands.

    Market Segment Insights

    By Type: Fine Needle Aspiration Biopsy (Largest) vs. Core Needle Biopsy (Fastest-Growing)

    In the Needle Biopsy Market, Fine Needle Aspiration Biopsy (FNAB) holds the largest market share among the various types of needle biopsies, due to its minimally invasive nature and effective performance in obtaining cells for diagnostic purposes. Core Needle Biopsy (CNB) follows closely, preferred for its ability to provide larger tissue samples, making it increasingly popular among healthcare providers. Vacuum-Assisted Biopsy (VAB) is also gaining traction, being utilized primarily in cases where more comprehensive tissue samples are necessary, but it still lags behind FNAB and CNB in terms of adoption. Growth trends indicate a substantial rise in Core Needle Biopsies as newer technologies enhance its efficiency and accuracy, rendering it an attractive option for both clinicians and patients. The demand for minimally invasive procedures is driving the market towards FNAB, while the emerging need for more substantial tissue sampling is pushing the growth of CNB. Moreover, increasing awareness about the advantages of VAB, particularly in complex cases, suggests a burgeoning interest in this segment as it captures the attention of medical professionals looking for reliable alternatives.

    Fine Needle Aspiration Biopsy (Dominant) vs. Vacuum-Assisted Biopsy (Emerging)

    Fine Needle Aspiration Biopsy (FNAB) has established itself as the dominant method in the Needle Biopsy Market, renowned for its efficiency, patient comfort, and ability to accurately diagnose various conditions with minimal tissue disruption. It is particularly advantageous in diagnosing thyroid, breast, and lymph node conditions. In contrast, Vacuum-Assisted Biopsy (VAB) is an emerging player, increasingly favored in scenarios requiring extensive tissue evaluation due to its capability to extract larger samples. While still gaining momentum, VAB's application ranges from breast lesions to other solid masses, driven by advancements in biopsy technology that enhance precision and patient outcomes, making it a compelling choice for hospitals seeking to improve diagnostic accuracy.

    By Application: Oncology (Largest) vs. Pulmonology (Fastest-Growing)

    The Needle Biopsy Market demonstrates a clear differentiation among its application segments, with oncology leading the market share due to its critical role in cancer diagnostics and treatment. Cardiology, gastroenterology, and pulmonology follow, each contributing to a diverse portfolio of procedures that capitalize on the precision of needle biopsy techniques in various medical contexts. This distribution underscores the importance of tailored approaches to therapeutic interventions based on specific organ systems and conditions.

    Oncology: Dominant vs. Pulmonology: Emerging

    Oncology remains the dominant force within the Needle Biopsy Market, driven by the increasing incidence of cancer and the growing need for accurate diagnosis and treatment options. Its established presence reflects extensive research, advanced technologies, and skilled professionals who specialize in cancer care. In contrast, pulmonology is emerging as the fastest-growing segment, fueled by heightened awareness around respiratory diseases and advancements in minimally invasive techniques. The rise in lung cancer cases and the need for accurate tissue sampling in pulmonary conditions are propelling this segment forward, capturing the attention of healthcare providers committed to improving patient outcomes.

    By Guidance Technique: Ultrasound Guided (Largest) vs. CT Guided (Fastest-Growing)

    In the Needle Biopsy Market, the Ultrasound Guided segment maintains a significant lead, representing the largest share among guidance techniques. This method has gained popularity due to its accessibility and precision, making it the preferred choice for many healthcare providers. Conversely, the CT Guided segment, although smaller in market share, is rapidly gaining traction due to its advanced imaging capabilities, allowing for high accuracy in complex cases.

    Ultrasound Guided: Dominant vs. CT Guided: Emerging

    The Ultrasound Guided technique is favored for its real-time imaging and ability to provide immediate feedback, making it a dominant player in the Needle Biopsy Market. This technique enables minimal invasiveness and faster recovery times for patients. Meanwhile, the CT Guided approach is emerging as a powerful alternative, particularly in difficult anatomical locations where ultrasound may be limited. By utilizing advanced imaging technology, CT Guided biopsies can target lesions that might otherwise go undetected, contributing to its rapid growth trajectory. As technology continues to evolve, both segments are expected to adapt and potentially redefine standards of care in needle biopsy procedures.

    By End Use: Hospitals (Largest) vs. Diagnostic Laboratories (Fastest-Growing)

    The Needle Biopsy Market demonstrates a varied distribution of market share among its end-use segment, prominently featuring hospitals, which represent the largest portion due to their broad capacity for a range of procedures. Hospitals have established a significant role in this market segment, capitalizing on their ability to provide comprehensive healthcare services and the availability of advanced diagnostic equipment. In contrast, diagnostic laboratories are rapidly gaining ground, showing the fastest growth due to the increasing demand for precise and swift biopsy results, essential for effective patient management.

    Hospitals (Dominant) vs. Research Institutions (Emerging)

    Hospitals play a dominant role in the Needle Biopsy Market, owing to their extensive resources, trained staff, and a wide array of services that include surgical interventions and diagnostic imaging. They are equipped with advanced technologies that facilitate efficient biopsy procedures, thereby attracting a larger patient base. Conversely, research institutions are emerging players in this segment, focusing on innovative biopsy techniques and methods. They are pivotal in advancing the scientific and medical understanding of biopsies through research initiatives, thus carving out a niche within the market that is likely to expand as technology and methodologies evolve.

    Get more detailed insights about Needle Biopsy Market

    Regional Insights

    The Regional segmentation of the Needle Biopsy Market reveals diverse trends, growth rates, and opportunities across various areas. In 2023, North America held a significant share with a valuation of 1.1 USD Billion, expected to grow to 1.65 USD Billion by 2032, marking it as the dominant region due to advanced healthcare infrastructure and high demand for minimally invasive procedures.

    Europe follows with a valuation of 0.65 USD Billion in 2023 and an increase to 1.0 USD Billion by 2032, demonstrating a robust market driven by increasing awareness and technological advancements.The APAC region, valued at 0.35 USD Billion in 2023 and projected to reach 0.55 USD Billion by 2032, is gaining momentum due to a rise in healthcare expenditure and growing patient populations.

    South America and MEA show smaller market sizes, with valuations of 0.07 USD Billion in 2023 for both, reflecting emerging opportunities but also challenges such as healthcare accessibility and regional economic conditions; however, MEA is anticipated to show a faster growth trajectory relative to South America, highlighting its potential in the Needle Biopsy Market revenue.These insights provide a comprehensive understanding of the Needle Biopsy Market segmentation and its regional variations that drive market growth and opportunities.

    Needle Biopsy Market Regional Insights

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    The Needle Biopsy Market is characterized by a dynamic competitive landscape, where innovation and technological advancements are pivotal to staying ahead. The market is witnessing increased adoption of minimally invasive procedures, leading to a rise in demand for needle biopsy instruments across various healthcare settings. Factors such as the growing prevalence of cancers and other chronic diseases contribute to the substantial market growth. Various players in the field are focusing on product development, collaborations, and strategic partnerships to enhance their market position.

    As competition intensifies, companies are investing heavily in research and development to introduce cutting-edge technologies that improve accuracy and efficiency in needle biopsies, ensuring that they can meet the evolving needs of healthcare providers and patients alike.Siemens Healthineers stands out in the Needle Biopsy Market due to its commitment to innovative solutions that enhance diagnostic accuracy and accelerate procedural workflow. The company emphasizes incorporating advanced imaging technologies that support precise localization during needle biopsies, thereby minimizing procedural errors.

    Siemens Healthineers has established a strong presence in this market through its comprehensive portfolio of imaging equipment, which greatly complements needle biopsy procedures. Their well-established reputation for quality and reliability allows them to maintain trust among practitioners and institutions. With an emphasis on continuous improvement and customer feedback, Siemens Healthineers focuses on tailoring its offerings to meet specific clinical requirements, ultimately improving patient outcomes and solidifying its position in the market.Stryker is recognized for its strategic initiatives and high-quality products within the Needle Biopsy Market.

    The company has made significant investments in developing advanced needle biopsy systems that emphasize user-friendly designs, enhanced ergonomics, and innovative technologies. Stryker’s dedication to understanding the needs of healthcare professionals enables it to deliver solutions that not only improve the ease of use but also promote accurate and efficient diagnostic procedures. The company enjoys a solid market presence driven by its extensive distribution network and strong relationships with healthcare providers.

    Stryker’s commitment to delivering high-performance products and a wide range of needle biopsy instruments positions it favorably in the competitive landscape, allowing it to respond effectively to the increasing demand for precision in biopsies.

    Key Companies in the Needle Biopsy Market market include

    Industry Developments

    The Needle Biopsy Market has recently witnessed significant developments, particularly involving key players such as Siemens Healthineers, Stryker, Cook Medical, Thermo Fisher Scientific, and others. Notably, advancements in imaging technologies are enhancing the accuracy and efficiency of needle biopsies, thereby increasing their demand across various medical fields. Current affairs indicate a growing emphasis on minimally invasive procedures, which is driving innovation in biopsy devices and techniques. Additionally, there has been a surge in mergers and acquisitions within the market, with companies like Abbott Laboratories and Boston Scientific actively pursuing strategic collaborations to expand their product portfolios and market reach.

    Such activities reflect a competitive landscape aimed at leveraging technological advancements and improving patient outcomes. The overall growth in market valuation for these companies is fostering more research and investment, significantly impacting the needle biopsy market by enhancing the availability of advanced diagnostic solutions, ultimately benefiting healthcare providers and patients alike.

    Future Outlook

    Needle Biopsy Market Future Outlook

    The Needle Biopsy Market is projected to grow at a 4.91% CAGR from 2024 to 2035, driven by technological advancements, increasing cancer prevalence, and rising demand for minimally invasive procedures.

    New opportunities lie in:

    • Development of advanced imaging-guided biopsy systems
    • Expansion of telemedicine platforms for remote consultations
    • Introduction of biodegradable biopsy needles for enhanced patient safety

    By 2035, the Needle Biopsy Market is expected to achieve substantial growth, reflecting evolving healthcare needs.

    Market Segmentation

    Needle Biopsy Market Type Outlook

    • Fine Needle Aspiration Biopsy
    • Core Needle Biopsy
    • Vacuum-Assisted Biopsy

    Needle Biopsy Market End Use Outlook

    • Hospitals
    • Diagnostic Laboratories
    • Research Institutions

    Needle Biopsy Market Application Outlook

    • Oncology
    • Cardiology
    • Gastroenterology
    • Pulmonology

    Needle Biopsy Market Guidance Technique Outlook

    • Ultrasound Guided
    • CT Guided
    • Mammography Guided

    Report Scope

    MARKET SIZE 20242.35(USD Billion)
    MARKET SIZE 20252.465(USD Billion)
    MARKET SIZE 20353.982(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR)4.91% (2024 - 2035)
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR2024
    Market Forecast Period2025 - 2035
    Historical Data2019 - 2024
    Market Forecast UnitsUSD Billion
    Key Companies ProfiledMarket analysis in progress
    Segments CoveredMarket segmentation analysis in progress
    Key Market OpportunitiesAdvancements in imaging technologies enhance precision and efficiency in the Needle Biopsy Market.
    Key Market DynamicsTechnological advancements and regulatory changes drive innovation and competition in the needle biopsy market.
    Countries CoveredNorth America, Europe, APAC, South America, MEA

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    What is the expected market size of the Needle Biopsy Market in 2035?

    The Needle Biopsy Market is expected to be valued at 3.98 USD Billion in 2035.

    What is the forecasted compound annual growth rate (CAGR) for the Needle Biopsy Market from 2025 to 2035?

    The Needle Biopsy Market is projected to have a CAGR of 5.0% from 2025 to 2035.

    Which region is expected to hold the largest market share in 2035?

    North America is expected to hold the largest market share, valued at 1.65 USD Billion in 2035.

    What is the expected market size for Fine Needle Aspiration Biopsy by 2035?

    The Fine Needle Aspiration Biopsy segment is expected to reach 1.4 USD Billion in 2035.

    What will be the market size of the Core Needle Biopsy segment in 2032?

    The Core Needle Biopsy segment is anticipated to be valued at 1.5 USD Billion in 2035.

    Who are the major players in the Needle Biopsy Market?

    Major players include Siemens Healthineers, Stryker, Cook Medical, and Thermo Fisher Scientific.

    What is the projected market value of Vacuum-Assisted Biopsy in 2035?

    The Vacuum-Assisted Biopsy segment is expected to reach 0.55 USD Billion in 2035.

    What is the expected market size for Europe in 2032?

    The European market is expected to be valued at 1.0 USD Billion by 2035.

    What challenges does the Needle Biopsy Market face?

    Challenges include regulatory hurdles and competition among key players.

    What is the growth rate expected for the Asia-Pacific region from 2024 to 2032?

    The Asia-Pacific region is expected to see a market growth reaching 0.55 USD Billion by 2035.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization
    Direct Access to Analyst
    Deliverable Format
    Platform Access
    Discount on Next Purchase 10% 15% 15%
    Printable Versions